PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,976 stories, page 780 of 783

Advanced search
🌍Regulatoryhealth.gov.ttTier 1 · Regulatory source

Eric Williams Medical Sciences Complex

Ministry of Health (Trinidad & Tobago)Original source
🌍Regulatoryhealth.gov.ttTier 1 · Regulatory source

Couva Hospital and Multi-Training Facility

Ministry of Health (Trinidad & Tobago)Original source
🌍Regulatoryhealth.gov.ttTier 1 · Regulatory source

Children's Life Fund Authority | Ministry of Health

Ministry of Health (Trinidad & Tobago)Original source
🌍Regulatoryhealth.gov.ttTier 1 · Regulatory source

Apply for a Licence to Operate a Private Home/Hospital

Ministry of Health (Trinidad & Tobago)Original source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Receives Approvals for Seven Generic Drugs with 12 Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Announces Listing of Six Generic Drugs with Nine Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Receives Approvals for Six Generic Drugs with Nine Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Announces Listing of Five Generic Drugs with Nine Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Receives Approvals for Five Generic Drugs with 11 Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Receives Approvals for a Single Generic Drug with One Strength | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Announces Listing of Five Generic Drugs with 10 Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Receives Approvals for Six Generic Drugs with 11 Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Announces Listing of Two Generic Drugs with Three Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Receives Approvals for Three Generic Drugs with Four Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Announces Listing of a single Generic Drug with Two Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Launch of Pitavastatin tablets in the United States – Sawai’s First generic ANDA approval and launch for US market under Paragraph IV– | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Announces Listing of Two Generic Drugs with Eight Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Receives Approvals for Three Generic Drugs with 10 Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Dec. 27. 2022 Sawai Pharmaceutical Applies for Marketing and Manufacturing Approval for Non-Invasive Neuromodulation Device

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Announces Listing of Six Generic Drugs with 12 Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Receives Approvals for Six Generic Drugs with 13 Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Announces Listing of Five Generic Drugs with 11 Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇯🇵Industryglobal.sawai.co.jpTier 1 · Company source

Sawai Receives Approvals for Seven Generic Drugs with 14 Strengths | News | Sawai Pharmaceutical Co., LTD.-Global

Sawai PharmaceuticalOriginal source
🇮🇳Industryglandpharma.comTier 1 · Company source

Investors Subsidiary Financial Overview | Gland Pharma Limited

Gland Pharma (IR)Original source
🇮🇳Industryglandpharma.comTier 1 · Company source

Stock Exchange Announcements | Gland Pharma Limited

Gland Pharma (IR)Original source
🇮🇳Industryglandpharma.comTier 1 · Company source

Shareholders Informations | Gland Pharma Limited

Gland Pharma (IR)Original source
🇮🇳Industryglandpharma.comTier 1 · Company source

Contact Details for Investors| Gland Pharma Limited

Gland Pharma (IR)Original source
🇮🇳Industryglandpharma.comTier 1 · Company source

Disclosures under Regulation 46 of the LODR | Gland Pharma Limited

Gland Pharma (IR)Original source
🇮🇳Industryglandpharma.comTier 1 · Company source

Corporate Governance | Policies | Gland Pharma Limited

Gland Pharma (IR)Original source
🇮🇳Industryglandpharma.comTier 1 · Company source

Investors Annual Return Overview | Gland Pharma Limited

Gland Pharma (IR)Original source
🇮🇳Industryglandpharma.comTier 1 · Company source

Investors Annual Report Overview | Gland Pharma Limited

Gland Pharma (IR)Original source
🌍Industrygetzpharma.comTier 1 · Company source

Orthopaedics & Rheumatology Archives - Getz Pharma - We Care For Your Health

Getz PharmaOriginal source
🌍Industrygetzpharma.comTier 1 · Company source

Infectious Disease Archives - Getz Pharma - We Care For Your Health

Getz PharmaOriginal source
🌍Industrygetzpharma.comTier 1 · Company source

General Medicine Archives - Getz Pharma - We Care For Your Health

Getz PharmaOriginal source
🌍Industrygetzpharma.comTier 1 · Company source

Pulmonology Archives - Getz Pharma - We Care For Your Health

Getz PharmaOriginal source
🌍Industrygetzpharma.comTier 1 · Company source

[email protected]

Getz PharmaOriginal source
🌍Industrygetzpharma.comTier 1 · Company source

Wellness at the Core: Getz Pharma Hosts Metal Wellness Session for Employees - Getz Pharma - We Care For Your Health

Getz PharmaOriginal source
🌍Industrygetzpharma.comTier 1 · Company source

PAK-SEHAT Stakeholders and Investigators Meeting - Getz Pharma - We Care For Your Health

Getz PharmaOriginal source
🌍Industrygetzpharma.comTier 1 · Company source

Metabolic Health Forum Brought Together Pakistan’s Leading Healthcare Experts to Advance Metabolic Care - Getz Pharma - We Care For Your Health

Getz PharmaOriginal source
🌍Industrygetzpharma.comTier 1 · Company source

Celebrated World Pharmacists Day by Connecting Future Pharmacists with Industry Experts - Getz Pharma - We Care For Your Health

Getz PharmaOriginal source
🌍Industrygetzpharma.comTier 1 · Company source

Book Launch of Myth & Reality: Type II Diabetes & Disease Impact in Pakistan by Dr. Nauman Niaz - Getz Pharma - We Care For Your Health

Getz PharmaOriginal source
🇺🇸Industrygeneratebiomedicines.comTier 1 · Company source

World Lung Day: Laurie Lee on AI, Immunology, and the Future of…

Generate BiomedicinesOriginal source
🇺🇸Industrygeneratebiomedicines.comTier 1 · Company source

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th…

Generate BiomedicinesOriginal source
🇺🇸Industrygeneratebiomedicines.comTier 1 · Company source

First-in-Human Results for GB- 0669 : Durable Neutralization from an AI-Designed Antibody

Generate BiomedicinesOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Welcome to Prequalification of In Vitro Diagnostics & Medical Devices

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

In Vitro Diagnostics Under Assessment

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

In Vitro Diagnostics Eligible for WHO Prequalification

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Support to Manufacturers

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Prequalification Procedures and Fees: In Vitro Diagnostics

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Post-prequalification Procedures & Fees: Prequalified IVDs

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Expert Review Panel for Diagnostics

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Collaborative Procedure for Accelerated Registration

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

UNFPA listed Contraceptives acknowledged by WHO

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Prequalification Procedure and Fees: Medical Devices

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Medical devices eligible for Prequalification

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

WHO Product Standards for Immunization Devices

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

WHO Catalogue of Prequalified Immunization Devices

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Product Testing Support for Manufacturers

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Product Testing Support for Laboratories

WHO PrequalificationOriginal source
🌍Regulatoryextranet.who.intTier 1 · Regulatory source

Prequalification Procedures and Fees: Immunization Devices

WHO PrequalificationOriginal source